Delivery, Uptake and Acceptability of HPV Vaccination in Tanzanian Girls.
Phase of Trial: Phase IV
Latest Information Update: 18 Jun 2012
At a glance
- Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Cervical cancer; Cervical intraepithelial neoplasia; Genital warts; Human papillomavirus infections
- Focus Therapeutic Use
- 18 Jun 2012 Primary endpoint results published in the Journal of Infectious Diseases.
- 07 Nov 2011 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.
- 07 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.